Why the study?
Information on the genetic diversity of noroviruses circulating in the 1980s and 1990s, prior to dedicated molecular assays, is limited compared with recent decades.
What are the epidemiological and evolutionary dynamics of noroviruses in children hospitalized with acute gastroenteritis over a 35-year period?
What are the epidemiological and evolutionary dynamics of noroviruses in children hospitalized with acute gastroenteritis over a 35-year period?
Long-term surveillance of norovirus in hospitalized children reveals continuous and rapid modification of the viral genomic makeup, highlighting the importance of surveillance for vaccine design.
Answers are grounded in this paper and cite their sources.
Norovirus strains evolved rapidly over 35 years; leaves open optimal strain selection for vaccines and supports ongoing surveillance.
Norovirus is recognised as a major cause of epidemic and sporadic acute gastroenteritis (AGE) in all age groups. Information on the genetic diversity of the noroviruses circulating in the 1980s and 1990s, before the development and adoption of dedicated molecular assays, is limited compared with the last decades. Between 1986 and 2020, uninterrupted viral surveillance was conducted in symptomatic children hospitalized with AGE in Palermo, Italy, providing a unique time capsule for exploring the epidemiological and evolutionary dynamics of enteric viruses. A total of 8433 stool samples were tested using real-time RT-PCR. All samples were stored at -20 or -80 °C until processing. In this 35-year long time span, noroviruses of genogroup II (GII) were detected in 15.6% of AGE requiring hospitalization, whilst GI noroviruses were detected in 1.4% of AGE. Overall, the predominant norovirus capsid (Cap) genotype was GII.4 (60.8%), followed by GII.3 (13.3%) and GII.2 (12.4%). Temporal replacement of the GII.4 Cap variants associated with different polymerase (Pol) types were observed over the study period. The chronology of emergence and circulation of the different GII.4 variants were consistent with data available in the literature. Also, for GII.3 and GII.2 NoVs, the circulation of different lineages/strains, differing in either the Cap or Pol genes or in both, was observed. This long-term study revealed the ability of noroviruses to continuously and rapidly modify their genomic makeup and highlights the importance of surveillance activities in vaccine design.
No takes yet. Share an insight, caveat, or question.
Bonura et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: